NASDAQ
AzurRx BioPharma, Inc. (AZRX) has a free cash flow growth of -364.38% as of Friday, May 29, 2026. This represents a 1.32% increase compared to its 12-month average of -369.24%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.